We use cookies to enhance your browsing experience and analyze site traffic. By continuing to use this site, you agree to our cookie policy. Privacy Policy
About Clickmab
Clickmab is focused on AI-driven antibody design. Built on proprietary large models, extensive proprietary antibody data, and a multi-agent architecture, the Click.mAb. platform supports antibody discovery and engineering optimization across the full R&D workflow for biopharmaceutical teams.
Generative AI for Fully Human Shared-Light-Chain De Novo Antibody Design
User-specified functional epitope
De novo designed antibody
Core Platform Capabilities
Click.mAb. combines generative AI, computational design, and wet-lab validation to support antibody discovery from de novo candidate generation to iterative optimization, enabling antibody design against specific antigen epitopes through generative AI models.
Core Technical Advantages
Proprietary Wet-Lab Data
Large-scale in-house wet-lab datasets for model training, testing, and continuous optimization.
Advanced AI Algorithms
Proprietary antibody design algorithms for precise and efficient candidate generation.
AI Agent Technology
Multi-agent workflows that automate task planning, tool execution, and result analysis.
Core Team Capabilities
An interdisciplinary team spanning AI, structural biology, antibody engineering, and wet-lab validation.
AI & Computational Modeling
prediction team.Expertise in AI algorithms, protein language models, and structure prediction for antibody design.
Structural Biology
Deep expertise in protein structure, biophysics, and antigen–antibody interactions.
Antibody Engineering
Experienced in antibody discovery, engineering, optimization, and translational development.
Wet-Lab Validation
In-house wet-lab capabilities enabling rapid design–build–test feedback loops.
Partner With Us
Whether you are a pharmaceutical company, biotech company, or academic institution, we would be glad to explore how Click.mAb. can support your antibody discovery and development programs.